Following this in vivo mechanistic study, it was shown in a therapeutic study that administration of 37 MBq [64Cu][Cu(ATSM)] inhibited tumor growth, decreased the CD133+ cell percentage, and the ability to metastasize [57]. Here, PROM1 is linked to neoplasm.